Compare CULP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CULP | ICCM |
|---|---|---|
| Founded | 1972 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Textiles | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.7M | 43.4M |
| IPO Year | N/A | N/A |
| Metric | CULP | ICCM |
|---|---|---|
| Price | $3.52 | $0.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 20.7K | ★ 214.8K |
| Earning Date | 03-04-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $204,919,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | $6.83 | $31.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.33 | $0.54 |
| 52 Week High | $5.64 | $1.66 |
| Indicator | CULP | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 41.95 |
| Support Level | $3.42 | $0.59 |
| Resistance Level | $3.69 | $0.63 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 18.51 | 40.74 |
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.